News items related to: News
-
J&J urged to reduce the price of breakthrough TB drug, bedaquiline
We’re supporting MSF’s #NoMoreTears campaign, demanding Johnson & Johnson to lower the price of the tuberculosis drug bedaquiline to $1...
-
Unprecedented complaint to the Brazilian Antitrust Authority (CADE) denounces abuse on hepatitis C drug pricing
Based on a study conducted by researchers of the University of São Paulo, civil society organizations call for action to...
-
Journalists’ training in Ukraine: Reporting on barriers to treatment
Earlier this month (5 September), journalists joined an event arranged by our partner, 100% Life, in Kyiv, Ukraine, for training...
-
The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries
A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...
-
The EU-Mercosur trade deal: Will it go up in flames before it’s ratified?
After 20 years, political agreement has been reached on a free trade agreement (FTA) between the EU and the South...
-
Apply to join ITPC’s Patent Opposition Academy
Applications are open to the Patent Oppositions Academy (the Academy) 2019-2021 for applicants living in El Salvador, Guatemala, Honduras and...
-
Brazilian Health Minister’s speech on compulsory licenses exposes a disconnect with the world
Adapted from a story first published by GTPI. Compulsory licensing is a vital public policy tool to combat the high...
-
World Hepatitis Day 2019: 1.4 million lives lost since last year
Today, 28 July, is World Hepatitis Day 2019. Since the day was marked in 2018, another 1.4 million people have...
-
ITPC’s IAS 2019 highlights!
The International AIDS Society (IAS) conferences are always bursting with events, announcements and debates, and the 10th International Conference on...
-
IAS 2019: Activists demand universal access to medicines
Today in Mexico City, dozens of treatment activists at the International AIDS Society (IAS) conference took over several drug company...
-
AIDS activists demand access to important cryptococcal meningitis drug
At the 10th International HIV Conference on Science (IAS 2019) taking place in Mexico City, AIDS activists protested Gilead’s inaction...
-
The right to health is compulsory: Time for action on dolutegravir – now!
Why Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...